U.S. market Closed. Opens in 5 hours 45 minutes

CLLS | Cellectis S.A. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Revenue755.00K19.17M73.95M73.95M15.19M12.73M25.19M53.77M55.04M26.30M22.82M27.81M20.73M20.98M17.32M14.77M4.10M
Cost of Revenue19.22M1.77M36.27M36.27M11.39M2.74M2.62MN/A2.71M3.69M847.86K2.03M3.26M1.92M2.33M1.54M1.48M
Gross Profit-18.47M17.40M37.67M37.67M3.80M9.99M22.57M53.77M52.34M22.61M21.97M25.78M17.47M19.06M14.99M13.23M2.62M
Operating Expenses88.16M107.06M123.11M123.11M127.35M115.08M115.22M104.86M82.86M28.98M67.13M51.92M42.78M34.31M27.51M18.03M10.41M
Selling, General & Admin511.00K17.49M44.20M44.20M43.02M47.25M53.89M41.26M36.44M22.51M48.63M25.83M26.69M17.90M7.97M5.70M4.28M
Research & Development87.65M97.50M86.95M86.95M92.04M76.57M79.23M-74.73M57.30M17.52M34.44M25.10M15.95M16.37MN/AN/AN/A
Other Operating Expenses-7.14M-7.93M-8.04M-8.04M-7.71M-25.42M-17.90M138.33M-10.88M-11.05M-15.95M995.85K142.57K35.91K19.54M12.32M6.13M
Operating Income-106.63M-89.67M-85.44M-85.44M-123.55M-105.09M-92.65M363.00K-30.53M-6.38M-45.16M-26.14M-25.31M-15.25M-12.52M-4.80M-7.78M
Other Expenses / Income-16.42M-8.94M-12.05M-12.05M8.34M10.51M-11.03M-64.43M8.25M8.63M-35.93M-1.74M173.68K486.77K798.04K1.12M810.65K
Before Tax Income-123.05M-98.60M-97.48M-97.48M-115.21M-88.33M-103.68M-64.06M-22.27M2.25M-81.09M-27.87M-25.14M-14.76M-11.72M-3.68M-6.97M
Income Tax Expenses-6.21M87.00K-11.20M-24.91M-24.53M16.81MN/AN/AN/AN/A4.68M1.58M5.76M-4.04M-6.20M-3.87M-2.61M
Net Income-101.06M-98.69M-86.28M-72.57M-90.69M-78.69M-99.37M-64.06M-22.46M24.32K-84.28M-29.45M-30.90M-10.72M-5.52M185.15K-4.36M
Interest Expenses5.31M3.79M5.34M12.05M2.61M46.00K4.00KN/A22.96K195.78K407.36KN/A632.49K203.48K8.60K13.92K29.16K
Basic Shares Outstanding57.01M45.55M44.82M42.50M42.44M40.77M35.69M35.29M34.15M26.07M20.65M20.48M14.13M14.13M14.13M14.13M14.13M
Diluted Shares Outstanding57.01M45.55M44.82M42.50M42.44M40.77M35.72M35.81M34.52M26.19M20.65M20.48M14.13M14.13M14.13M14.13M14.13M
EBITDA-88.10M-89.67M-85.44M-85.44M-123.55M-105.09M-95.99M-61.96M-20.53M1.89M-33.25M-27.87M-24.50M-12.98M-11.34M-3.27M-6.09M
EBITDA Margin-11,669.27%-467.72%-115.54%-115.54%-813.38%-825.47%-381.12%-115.25%-37.30%7.18%-145.75%-100.21%-118.21%-61.87%-65.49%-22.13%-148.45%
EBIT-101.96M-94.81M-92.14M-85.44M-112.61M-61.84M-99.36M-64.06M-22.44M220.10K-79.19M-27.87M-24.50M-14.56M-11.71M-3.67M-6.94M
EBIT Margin-13,505.03%-494.57%-124.61%-115.54%-741.32%-485.75%-394.51%-119.15%-40.76%0.84%-347.07%-100.21%-118.21%-69.39%-67.61%-24.84%-169.25%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙